Series B - De Novo Pharmaceuticals - Jul 26, 2001 Funding Round Profile - Cointime

Bitcoin $79,966.90 +4.50%
Ethereum $3,224.60 +5.60%
BNB $642.79 +2.79%
Optimism $1.70 +2.88%
Arbitrum $0.65 +5.53%
Solana $207.08 +2.49%
Polygon $0.41 +5.39%
Cosmos $5.29 +11.14%
Avalanche $32.12 +8.95%

Bitcoin $79,966.90 +4.50%
Ethereum $3,224.60 +5.60%
BNB $642.79 +2.79%
Optimism $1.70 +2.88%
Arbitrum $0.65 +5.53%
Solana $207.08 +2.49%
Polygon $0.41 +5.39%
Cosmos $5.29 +11.14%
Avalanche $32.12 +8.95%

De Novo Pharmaceuticals

company

Funding Round

Series B

Money Raised

£ 16.75M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Prelude Trust	-	-	-	Detail
FNI Venture Capital	-	-	-	Detail
The Cambridge Gateway Fund	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Apr 18, 2000	Series A	£ 2M	Prelude Trust	Detail